Hypericin‐based fluorescence diagnosis of bladder carcinoma

Objective To determine the use of hypericin instillation for the fluorescent detection of papillary bladder cancer and carcinoma in situ.

[1]  L. Baert,et al.  Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. , 2000, The Journal of urology.

[2]  P. D. de Witte,et al.  Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. , 2000, Cancer letters.

[3]  L. Guillou,et al.  ©1999 Cancer Research Campaign Article no. bjoc.1998.0338 , 2022 .

[4]  P. Vandenabeele,et al.  Hypericin‐induced photosensitization of HeLa cells leads to apoptosis or necrosis , 1998, FEBS letters.

[5]  W. Merlevede,et al.  Photocytotoxic effect of pseudohypericin versus hypericin. , 1998, Journal of photochemistry and photobiology. B, Biology.

[6]  W. Merlevede,et al.  Cytotoxicity and Antiproliferative Effect of Hypericin and Derivatives after Photosensitization , 1998, Photochemistry and photobiology.

[7]  M. Hazzard.  Klaus Linde, Gilbert Ramirez, Cynthia D. Mulrow, Andrej Pauls, Wolfgang Weidenhammer, and Dieter Melchart. (1996). St. John's wort for depression—An overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 3 August 1996, 253-8 , 1997 .

[8]  W. Merlevede,et al.  Differential cytotoxic effects induced after photosensitization by hypericin. , 1997, Journal of photochemistry and photobiology. B, Biology.

[9]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[10]  R Baumgartner,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.

[11]  L. Baert,et al.  Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. , 1995, Urology.

[12]  D. Meruelo,et al.  The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities , 1995, Medicinal research reviews.

[13]  R Baumgartner,et al.  Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. , 1994, Urology.

[14]  P. Alken,et al.  Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom , 1994 .

[15]  K Svanberg,et al.  Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. , 1993, Urology.

[16]  H. Falk,et al.  A convenient semisynthetic route to hypericin , 1993 .

[17]  Marie-Ange D'Hallewin,et al.  Whole bladder wall photodynamic therapy with in-situ light dosimetry for carcinoma in situ of the bladder , 1992, Photonics West - Lasers and Applications in Science and Engineering.

[18]  H. Zincke,et al.  Carcinoma in Situ of the Bladder , 1980, Cancer.

[19]  P. Agostinis,et al.  Photodynamic activity of hypericin in human urinary bladder carcinoma cells. , 2000, Anticancer research.

[20]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[21]  H Stepp,et al.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.

[22]  F. Algaba,et al.  Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. , 1987, European urology.